Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis

Oncogene

Volumn 27, Issue 8, 2008, Pages 1087-1094

  Chan, K S ^a   Sano, S ^a   Kataoka, K ^a   Abel, E ^a   Carbajal, S ^a   Beltran, L ^a   Clifford, J ^b   Peavey, M ^a   Shen, J ^a   DiGiovanni, J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiogenesis and epithelial mesenchymal transition; Epithelial carcinogenesis; Malignant progression; Stat3

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; FILAGGRIN; GROWTH FACTOR; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN K10; STAT3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DIMERIZATION; EPIDERMIS; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPIDERMIS; KERATINOCYTES; MICE; MICE, TRANSGENIC; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE;

MUS; MUS MUSCULUS;

EID: 39149129602     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210726     Document Type: Article

References (29)

1. Bowman T, Garcia R, Turkson J, Jove R. (2000). STATs in oncogenesis. Oncogene 19: 2474-2488.
2. Bromberg J. (2002). Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142.
3. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C et al. (1999). Stat3 as an oncogene. Cell 98: 295-303.
4. Cano A, Gamallo C, Kemp CJ, Benito N, Palacios J, Quintanilla M et al. (1996). Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice. Int J Cancer 65: 254-262.
5. Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J. (2004a). Epidermal growth factor receptor-mediated activation of stat3 during multistage skin carcinogenesis. Cancer Res 64: 2382-2389.
6. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J et al. (2004b). Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 114: 720-728.
7. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R et al. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408.
8. Faraldo ML, Rodrigo I, Behrens J, Birchmeier W, Cano A. (1997). Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Mol Carcinog 20: 33-47.
9. Fuchs E. (1994). Epidermal differentiation and keratin gene expression. Princess Takamatsu Symp 24: 290-302.
10. Kalluri R, Neilson EG. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
11. Kang Y, Massague J. (2004). Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: 277-279.
12. Kiguchi K, Beltrán L, Rupp T, DiGiovanni J. (1998). Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors by an initiation-promotion protocol. Mol Carcinog 22: 73-83.
13. Kortylewski M, Jove R, Yu H. (2005). Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 24: 315-327.
14. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL. (1998). VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17: 303-311.
15. Levy DE, Darnell Jr JE. (2002). Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
16. Ling X, Arlinghaus RB. (2005). Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res 65: 2532-2536.
17. Miller DR, Viaje A, Aldaz CM, Conti CJ, Slaga TJ. (1987). Terminal differentiation-resistant epidermal cells in mice undergoing two-stage carcinogenesis. Cancer Res 47: 1935-1940.
18. Navarro P, Gomez M, Pizarro A, Gamallo C, Quintanilla M, Cano A. (1991). A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol 115: 517-533.
19. Rho O, Beltrán L, Gimenez-Conti IB, DiGiovanni J. (1994). Altered expression of the epidermal growth factor receptor and transforming growth factor a during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11: 19-28.
20. Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P et al. (1998). Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev 12: 2469-2474.
21. Ruggeri B, Caamano J, Slaga TJ, Conti CJ, Nelson WJ, Klein-Szanto AJ. (1992). Alterations in the expression of uvomorulin and Na+,K(+)-adenosine triphosphatase during mouse skin tumor progression. Am J Pathol 140: 1179-1185.
22. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K et al. (2005). Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11: 43-49.
23. Suiqing C, Min Z, Lirong C. (2005). Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32: 354-360.
24. Tang MS, Vulimiri SV, Viaje A, Chen JX, Bilolikar DS, Morris RJ et al. (2000). Both (+/-)syn- and (+/-) anti-7,12-dimethylbenz[a]anthracene3,4- diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA-mutations at Codon 61 of c-H-ras. Cancer Res 60: 5688-5695.
25. Thiery JP. (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
26. Yamashita S, Miyagi C, Fukada T, Kagara N, Che YS, Hirano T. (2004). Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429: 298-302.
27. Yang J, Mani SA, Weinberg RA. (2006). Exploring a new twist on tumor metastasis. Cancer Res 66: 4549-4552.
28. Yuspa SH. (1994). The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. Cancer Res 54: 1178-1189.
29. Zeigler ME, Krause S, Karmiol S, Varani J. (1996). Growth factor-induced epidermal invasion of the dermis in human skin organ culture: dermal invasion correlated with epithelial cell motility. Invasion Metastasis 16: 3-10.